Dr. Minerva Wong is a law clerk in the New York office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patents and innovations practice. She focuses on patent prosecution and due diligence matters for clients in the life sciences industry. Minerva’s technical areas of expertise include neurobiology, cellular and molecular biology, immunology, and pharmacology.
Prior to joining the firm, Minerva completed her doctoral and postdoctoral trainings at Columbia University. Her research focused on developing novel techniques for understanding neuronal synapse interactions by detecting neurotransmitter uptake and release in real-time. She studied the molecular and cellular mechanisms underlying neurological disorders, including Parkinson’s disease.
Minerva is admitted to the U.S. Patent and Trademark Office. She is not yet admitted to any jurisdiction and therefore not yet authorized to practice law.
Dr. Minerva Wong is a law clerk in the New York office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patents and innovations practice. She focuses on patent prosecution and due diligence matters for clients in the life sciences industry. Minerva’s technical areas of expertise include neurobiology, cellular and molecular biology, immunology, and pharmacology.
Prior to joining the firm, Minerva completed her doctoral and postdoctoral trainings at Columbia University. Her research focused on developing novel techniques for understanding neuronal synapse interactions by detecting neurotransmitter uptake and release in real-time. She studied the molecular and cellular mechanisms underlying neurological disorders, including Parkinson’s disease.
Minerva is admitted to the U.S. Patent and Trademark Office. She is not yet admitted to any jurisdiction and therefore not yet authorized to practice law.
- J.D., Fordham University School of Law, 2024
- Postdoctoral Fellowship, Neurology, Columbia University, 2014
- Ph.D., Pharmacology and Molecular Signaling, Columbia University
- B.S., Biomedical Engineering, Columbia University, 2005
- U.S. Patent and Trademark Office
- Not yet admitted to practice in any jurisdiction
- J.D., Fordham University School of Law, 2024
- Postdoctoral Fellowship, Neurology, Columbia University, 2014
- Ph.D., Pharmacology and Molecular Signaling, Columbia University
- B.S., Biomedical Engineering, Columbia University, 2005
- U.S. Patent and Trademark Office
- Not yet admitted to practice in any jurisdiction
Select Publications
- Co-author, “Loss of striatonigral GABAergic presynaptic inhibition enables motor sensitization in parkinsonian mice,” 87(5) Neuron 976-988, 2015
- Co-author, “Dopamine-dependent corticostriatal synaptic filtering regulates sensorimotor behavior,” 290 Neuroscience 594-607, 2015
- Co-author, “Fluorescent dopamine tracer resolves individual dopaminergic synapses and their activity in the brain,” 110(3) Proceedings of the National Academy of Sciences USA 870-875, 2012
- Co-author, “Imaging presynaptic exocytosis in corticostriatal slices,” 793 Methods Molecular Biology 363-376, 2011
- Co-author, “Dopamine release at individual presynaptic terminals visualized with FFNs,” 30 Journal of Visualized Experiments 1562, 2009
- Co-author, “Fluorescent false neurotransmitters visualize dopamine release from individual presynaptic terminals,” 324(5933) Science 1441-1444, 2009
- Co-author, “Molecular modeling and mutagenesis reveals a tetradentate binding site for Zn2+ in GABA(A) alphabeta receptors and provides a structural basis for the modulating effect of the gamma subunit,” 48(2) Journal of Chemical Information and Modeling 344-349, 2008
- Co-author, “Taurine is a potent activator of extrasynaptic GABA(A) receptors in the thalamus,” 28(1) Journal of Neuroscience 106-115, 2008
- Co-author, “Isoflurane is a potent modulator of extrasynaptic GABA(A) receptors in the thalamus,” 324(3) Journal of Pharmacology and Experimental Therapeutics 1127-1135, 2008
- Co-author, “An extrasynaptic GABAA receptor mediates tonic inhibition in thalamic VB neurons,” 94(6) Journal of Neurophysiology 4491-4501, 2005
Select Publications
- Co-author, “Loss of striatonigral GABAergic presynaptic inhibition enables motor sensitization in parkinsonian mice,” 87(5) Neuron 976-988, 2015
- Co-author, “Dopamine-dependent corticostriatal synaptic filtering regulates sensorimotor behavior,” 290 Neuroscience 594-607, 2015
- Co-author, “Fluorescent dopamine tracer resolves individual dopaminergic synapses and their activity in the brain,” 110(3) Proceedings of the National Academy of Sciences USA 870-875, 2012
- Co-author, “Imaging presynaptic exocytosis in corticostriatal slices,” 793 Methods Molecular Biology 363-376, 2011
- Co-author, “Dopamine release at individual presynaptic terminals visualized with FFNs,” 30 Journal of Visualized Experiments 1562, 2009
- Co-author, “Fluorescent false neurotransmitters visualize dopamine release from individual presynaptic terminals,” 324(5933) Science 1441-1444, 2009
- Co-author, “Molecular modeling and mutagenesis reveals a tetradentate binding site for Zn2+ in GABA(A) alphabeta receptors and provides a structural basis for the modulating effect of the gamma subunit,” 48(2) Journal of Chemical Information and Modeling 344-349, 2008
- Co-author, “Taurine is a potent activator of extrasynaptic GABA(A) receptors in the thalamus,” 28(1) Journal of Neuroscience 106-115, 2008
- Co-author, “Isoflurane is a potent modulator of extrasynaptic GABA(A) receptors in the thalamus,” 324(3) Journal of Pharmacology and Experimental Therapeutics 1127-1135, 2008
- Co-author, “An extrasynaptic GABAA receptor mediates tonic inhibition in thalamic VB neurons,” 94(6) Journal of Neurophysiology 4491-4501, 2005
- Privacy Policy
- Terms of Use
- Accessibility